BOTOX(R) botulinum toxin type A has been licensed by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Marlow, United Kingdom last Jul 09, 2010 for Preventive Treatment of headaches in adults who have chronic migraine.
This is the first licence worldwide of BOTOX(R) as preventive treatment for patients with chronic migraine.
Chronic Migraine can be very expensive and a hard disorder that will give a big impact to those who are suffering from it.
Historically, treatment for chronic migraine has consisted of many combinations of over-the-counter and prescription treatments such as triptans, tricyclic antidepressants, B-blockers and anti-epileptics which usually not cheap and the effectiveness was not so strong.
BOTOX(R) is a prescription-only medical product that has tiny amounts of highly purified botulinum toxin protein refined from the bacterium,Clostridium botulinum.
Patients who may be suffering from chronic migraine should seek medical advice from neurologists or headache specialists to make sure proper diagnosis and care.
Wendy Thomas, Chief Executive of The Migraine Trust says, "Chronic migraine is currently an under-researched, under-diagnosed and under-treated condition.
We know that treatment with acute pain medication does not always work for these patients so we welcome new therapies, especially preventive medication, for this potentially disabling condition.
" Lee Tomkins, Director at Migraine Action comments, "It is important that patients seek a referral to a specialist for help with chronic migraine as the condition is so often associated with depression and other medical co-morbidities.
There are many headache clinics around the world offering specialist help and support to people with chronic migraine.
" In addition, BOTOX(R) in United Kingdom is also indicated for the treatment of blepharospasm which is uncontrolled blinking of the eyelids, hemifacial spasm which is a neuromuscular disorder characterised by unpredictable and involuntary twitching of facial muscles on one side of the face, cervical dystonia is a muscle condition affecting the neck making it difficult to hold the head up straight, severe axillary hyperhidrosis refer to excessive sweating of the armpits, cerebral palsy a dynamic equinus foot deformity in pediatric patients aged two years and older, and lastly upper limb spasticity or the wrist and hand disability associated with stroke in adults.
In the United States, BOTOX is manufactured by Allergan, Inc.
for both therapeutic and cosmetic use, but recently, Allergan Inc was charge 600 million USD by F.
D.
A.
Due to seeding up the market or stirring up excitement for a forthcoming product or application without waiting for the approval of the product in United States.
Lanzhou Institute in China manufactures a BTX-A product which another form of Botox originally introduced from Korea.
The authorisation of BOTOX(R) by (MHRA) of United kingdom marks an evolution in medical care for the prevention of headache in adults with chronic migraine.
It is also a significant milestone in the history of BOTOX(R), From Being a Plainly Cosmetic Product to Health Product!
This is the first licence worldwide of BOTOX(R) as preventive treatment for patients with chronic migraine.
Chronic Migraine can be very expensive and a hard disorder that will give a big impact to those who are suffering from it.
Historically, treatment for chronic migraine has consisted of many combinations of over-the-counter and prescription treatments such as triptans, tricyclic antidepressants, B-blockers and anti-epileptics which usually not cheap and the effectiveness was not so strong.
BOTOX(R) is a prescription-only medical product that has tiny amounts of highly purified botulinum toxin protein refined from the bacterium,Clostridium botulinum.
Patients who may be suffering from chronic migraine should seek medical advice from neurologists or headache specialists to make sure proper diagnosis and care.
Wendy Thomas, Chief Executive of The Migraine Trust says, "Chronic migraine is currently an under-researched, under-diagnosed and under-treated condition.
We know that treatment with acute pain medication does not always work for these patients so we welcome new therapies, especially preventive medication, for this potentially disabling condition.
" Lee Tomkins, Director at Migraine Action comments, "It is important that patients seek a referral to a specialist for help with chronic migraine as the condition is so often associated with depression and other medical co-morbidities.
There are many headache clinics around the world offering specialist help and support to people with chronic migraine.
" In addition, BOTOX(R) in United Kingdom is also indicated for the treatment of blepharospasm which is uncontrolled blinking of the eyelids, hemifacial spasm which is a neuromuscular disorder characterised by unpredictable and involuntary twitching of facial muscles on one side of the face, cervical dystonia is a muscle condition affecting the neck making it difficult to hold the head up straight, severe axillary hyperhidrosis refer to excessive sweating of the armpits, cerebral palsy a dynamic equinus foot deformity in pediatric patients aged two years and older, and lastly upper limb spasticity or the wrist and hand disability associated with stroke in adults.
In the United States, BOTOX is manufactured by Allergan, Inc.
for both therapeutic and cosmetic use, but recently, Allergan Inc was charge 600 million USD by F.
D.
A.
Due to seeding up the market or stirring up excitement for a forthcoming product or application without waiting for the approval of the product in United States.
Lanzhou Institute in China manufactures a BTX-A product which another form of Botox originally introduced from Korea.
The authorisation of BOTOX(R) by (MHRA) of United kingdom marks an evolution in medical care for the prevention of headache in adults with chronic migraine.
It is also a significant milestone in the history of BOTOX(R), From Being a Plainly Cosmetic Product to Health Product!
SHARE
